LIXT
Lixte Biotechnology Holdings Inc
3.70$
-1.3%
vs. previous close
Closing price · As of: Sep 3, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 100.0% | 99.9% | 99.9% | 99.8% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 99.9% | 100.0% | 100.0% | 100.0% | 100.0% | 98.2% | 90.7% | 40.7% | |
| 100.0% | 90.5% | 80.8% | 20.1% | 96.4% | 6.2% | 3.3% | 94.4% | 85.1% | 8.2% | 4.2% | 46.1% | 95.4% | 98.5% | 97.3% | 97.0% | 94.7% | 96.3% | 97.6% | 90.7% | 40.1% | |
| 100.0% | 90.5% | 80.8% | 20.1% | 98.0% | 89.1% | 85.0% | 94.8% | 86.2% | 47.9% | 21.6% | 46.1% | 95.4% | 98.5% | 97.3% | 97.0% | 94.7% | 96.3% | 97.6% | 90.7% | 40.1% | |
| – | – | – | – | – | 6.0% | – | – | – | – | 33.4% | – | – | – | 0.5% | – | – | – | – | – | – | |
| – | – | – | – | – | 2.3% | – | – | – | – | 10.2% | – | – | – | – | – | – | – | – | – | – | |
| 269.9% | 16.6% | 40.1% | 726.4% | 18.8% | 10.1% | 81.6% | 14.9% | 57.7% | 50.7% | 47.8% | 50.4% | 27.3% | 4.9% | 8.9% | 4.1% | 5.9% | 7.1% | 7.3% | 27.8% | 13.9% | |
| 269.9% | 16.6% | 40.1% | 726.4% | 18.8% | 10.1% | 81.6% | 14.9% | 57.7% | 50.7% | 47.8% | 50.4% | 27.3% | 4.9% | 8.9% | 4.1% | 5.9% | 7.1% | 7.3% | 27.8% | 10.5% | |
| – | – | – | 193.6% | – | – | – | 8.7% | 21.4% | 6.4% | 20.5% | 13.6% | 4.5% | 4.9% | 8.9% | – | 5.9% | 7.1% | 7.3% | – | 5.2% | |
| 316.3% | 4.2% | 11.7% | 179.5% | – | 5.3% | 25.4% | 4.6% | 19.3% | 22.7% | 26.6% | 36.8% | 22.8% | 4.5% | 5.4% | 3.6% | 4.4% | 4.1% | 3.6% | 7.3% | 3,427.8% | |
| -169.9% | 83.4% | 59.9% | -626.4% | 81.2% | 89.9% | 18.4% | 85.1% | 42.3% | 49.3% | 52.2% | 49.6% | 72.7% | 95.1% | 91.1% | 95.9% | 94.1% | 92.9% | 92.7% | 72.2% | 75.9% | |
| -709.8% | -67.1% | -353.9% | -6,772.5% | -315.3% | -307.0% | -1,861.0% | -660.4% | -2,321.0% | -2,914.6% | -3,105.9% | -4,777.7% | -1,645.8% | -568.4% | -1,013.8% | -580.5% | -728.1% | -780.5% | -1,125.2% | -4,545.4% | -456.1% | |
| 971,712.4% | 50,483.8% | 70,755.0% | 901,029.9% | 30,514.2% | 29,976.0% | 136,389.5% | 37.1% | 124.2% | 137.2% | 130.4% | 184.1% | 68.0% | 22.6% | 41.8% | 21.6% | 26.5% | 2.8% | 44.5% | 196.3% | 380.2% |
Data as of: September 3, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.